Announcements Trials
Browse Landscape

Status

Completed 20Recruiting 11Active not recruiting 9Unknown 8Not yet recruiting 4Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Postoperative Complications 1Ovarian Neoplasms 1Multiple Myeloma 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Geriatric Assessment × Clear all
NCT05276622 2024-12-12

PaCE-MM

UNC Lineberger Comprehensive Cancer Center

Terminated
64 enrolled
Plasma cell

Multiple Myeloma

NCT01175967 2015-10-12

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

UNC Lineberger Comprehensive Cancer Center

Terminated
11 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡